Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Bioprinting & 3D-Printing in the Life Sciences EU 2018

Bioprinting & 3D-Printing in the Life Sciences EU 2018 Agenda



Promises and Future of Bioprinting Technic in Cosmetic Evaluation

Maité Rielland, Advanced Research Engineer, Methods and Predictive Models, L’Oréal

Since the 80s, a long time before the 2013 European Union ban on animal testing for cosmetic products, L’Oréal has placed itself as a pioneer for reconstructed human skin. It became one of the first cosmetic companies testing its raw materials/actives/formulations on in-house reconstructed human skin and now selling them through Episkin, our production company in Lyon, France. Bioprinting is a great alternative to create new models of skin with a complexity that cannot be achieved only by human hands. One of the biggest potential advantages of this technology is the ability to place cells or biological material where it needs to be placed, opening a few doors for tissue engineering. It will be a tool for screening and model construction in the next few years and is already pushing us to think 3D in vitro models and Tissue Engineering differently.